130 related articles for article (PubMed ID: 7471057)
1. Comparative effects of different strains of Corynebacterium parvum on natural cell-mediated cytotoxicity.
Nasrallah AG; Gallagher MT; Priest EL; Trentin JJ
Cancer Res; 1980 Nov; 40(11):4159-64. PubMed ID: 7471057
[TBL] [Abstract][Full Text] [Related]
2. Augmentation of natural killer cell activity in spleens of infant, aged, and low responder strain mice by Corynebacterium parvum.
Gallagher MT; Nasrallah AG; Datta SK; Priest EL; Trentin JJ
Exp Hematol; 1981 Feb; 9(2):149-55. PubMed ID: 7238649
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of decline of natural killer cell activity in Corynebacterium parvum-treated mice: inhibition by erythroblasts and Thy 1.2+ lymphocytes.
Savary CA; Lotzová E
J Natl Cancer Inst; 1987 Sep; 79(3):533-41. PubMed ID: 2887687
[TBL] [Abstract][Full Text] [Related]
4. Effect of pregnancy on augmentation of natural killer cell activity by Corynebacterium parvum and Toxoplasma gondii.
Luft BJ; Remington JS
J Immunol; 1984 May; 132(5):2375-80. PubMed ID: 6715884
[TBL] [Abstract][Full Text] [Related]
5. Murine lymph node natural killer cells: regulatory mechanisms of activation or suppression.
Hisano G; Hanna N
J Natl Cancer Inst; 1982 Sep; 69(3):665-71. PubMed ID: 6180211
[TBL] [Abstract][Full Text] [Related]
6. In vitro augmentation of rat natural killer (NK) cell activity.
Reynolds CW; Herberman RB
J Immunol; 1981 Apr; 126(4):1581-5. PubMed ID: 6451648
[TBL] [Abstract][Full Text] [Related]
7. Splenic suppressor macrophages induced in mice by injection of Corynebacterium parvum.
Kirchner H; Holden HT; Herberman
J Immunol; 1975 Nov; 115(5):1212-6. PubMed ID: 1176773
[TBL] [Abstract][Full Text] [Related]
8. [Monitoring natural killer cell activity in the blood of patients with malignant pleural effusion after intrapleural administration of Corynebacterium parvum].
Marel M; Pospísil M; Fiserová A; Melínová L; Skácel Z; Bednár M
Cas Lek Cesk; 1990 Apr; 129(16):498-500. PubMed ID: 2340567
[TBL] [Abstract][Full Text] [Related]
9. Alteration in natural defense activity against NK-susceptible B16 melanoma cells after treatment with Corynebacterium parvum.
Karashima A; Taniguchi K; Yoshikai Y; Nomoto K
Immunobiology; 1991 Aug; 182(5):414-24. PubMed ID: 1916884
[TBL] [Abstract][Full Text] [Related]
10. Activation of peritoneal lymphocyte cytotoxicity in patients with ovarian cancer by intraperitoneal treatment with Corynebacterium parvum.
Lichtenstein A; Berek J; Bast R; Spina C; Hacker N; Knapp RC; Zighelboim J
J Biol Response Mod; 1984 Aug; 3(4):371-8. PubMed ID: 6541243
[TBL] [Abstract][Full Text] [Related]
11. The accumulated effects of repeated systemic or local injections of low doses of Corynebacterium parvum in mice.
Scott MT; Warner SL
Cancer Res; 1976 Apr; 36(4):1335-8. PubMed ID: 1083289
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of the antitumor-activity of Corynebacterium parvum by appropriate adjustment of dosage schedules.
Megirian R; Astry CL; Spoor RP; Loose L
Cancer Treat Rep; 1980; 64(8-9):915-20. PubMed ID: 7448829
[TBL] [Abstract][Full Text] [Related]
13. Antileukemia activity of a natural killer cell line against human leukemias.
Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of natural killer cell numbers but not function in leukemic infant mice: a system primed in infancy allows survival in adulthood.
Dussault I; Miller SC
Nat Immun; 1993; 12(2):66-78. PubMed ID: 8318817
[TBL] [Abstract][Full Text] [Related]
15. Neutrophils contribute to the biological antitumor activity of rituximab in a non-Hodgkin's lymphoma severe combined immunodeficiency mouse model.
Hernandez-Ilizaliturri FJ; Jupudy V; Ostberg J; Oflazoglu E; Huberman A; Repasky E; Czuczman MS
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5866-73. PubMed ID: 14676108
[TBL] [Abstract][Full Text] [Related]
16. Modulation of macrophage functions by corynebacterium parvum preparations.
Bonina L; Delfino D; Costa GB; Arena A
Boll Ist Sieroter Milan; 1989; 68(1):62-6. PubMed ID: 2491287
[TBL] [Abstract][Full Text] [Related]
17. Role of inflammatory neutrophils in antitumor effects induced by intraperitoneal administration of Corynebacterium parvum in mice.
Lichtenstein AK; Berek J; Kahle J; Zighelboim J
Cancer Res; 1984 Nov; 44(11):5118-23. PubMed ID: 6488171
[TBL] [Abstract][Full Text] [Related]
18. Progression of natural immunity during one-year treatment of residual disease in neuroblastoma patients with high doses of interleukin-2 after autologous bone marrow transplantation.
Martí F; Pardo N; Peiró M; Bertran E; Amill B; García J; Cubells J; Rueda F
Exp Hematol; 1995 Dec; 23(14):1445-52. PubMed ID: 8542930
[TBL] [Abstract][Full Text] [Related]
19. Modulatory effect of killed Propionibacterium acnes and its purified soluble polysaccharide on peritoneal exudate cells from C57Bl/6 mice: major NKT cell recruitment and increased cytotoxicity.
Ananias RZ; Rodrigues EG; Braga EG; Squaiella CC; Mussalem JS; Longhini AL; Travassos LR; Longo-Maugéri IM
Scand J Immunol; 2007 Jun; 65(6):538-48. PubMed ID: 17523946
[TBL] [Abstract][Full Text] [Related]
20. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
